The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
With the COVID-19 vaccination rollout still in its early stages, a KFF analysis finds that most older adults have not yet been vaccinated against the potentially deadly virus, as vaccine supplies remain limited and most states have only recently begun to make people 65 and older eligible.
In the January report from the COVID-19 Vaccine Monitor, the lack of information around where and when to get the COVID-19 vaccine is particularly pronounced among Hispanic and Black adults compared to White Adults. Learn more in this Chart of the Week.
This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.
A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines.
As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of contracting COVID-19 as well as hard-to-reach groups, Medicaid agencies can be important partners for the public health agencies that are typically leading the state COVID-19 vaccination efforts. This brief provides insights regarding how state Medicaid agencies are assisting with the COVID-19 vaccine roll-out including specific actions taken.
In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them." But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of 'wait and see' Americans.”
On March 19, 2021, the Biden Administration reached its goal of administering 100 million doses of the COVID-19 vaccine since President Biden’s inauguration on January 20, 2021, by closing the day at 118,313,818. As of that day, over one-fifth (23.5%) of the U.S. population had received at least one dose of the vaccine.
Among Those Who Have Not Been Vaccinated, 3 in 10 Are Unsure if They are Eligible Yet; Hispanic Adults and People with Low Incomes More Likely to Be Unsure The latest KFF COVID-19 Vaccine Monitor report finds enthusiasm for getting a COVID-19 vaccine continuing to grow, with roughly 6 in 10 adults (61%) now saying…
An analysis of Centers for Disease Control and Prevention (CDC) COVID-19 vaccination data from 72% of all counties in the U.S. shows that counties classified as having “low” COVID-19 community transmission (cases and positive tests) levels have an average vaccination rate greater than the rate in counties with “high” community transmission levels.
In this Axios column, Drew Altman examines why doctors and nurses are such critical messengers in the effort to build vaccine confidence.
© 2026 KFF